Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Do we need to temper our expectations of Paxlovid?

Benjamin Geisler, MD, MPH
Meds
September 10, 2022
51 Shares
Share
Tweet
Share

The twice-vaxxed, twice-boosted First Lady, Dr. Jill Biden, tested negative for COVID after taking Paxlovid. And then she rebounded, just like her husband did weeks ago or like Director of the National Institute of Allergy and Infectious Diseases (NIAID) and Chief Medical Advisor to the president Anthony Fauci did in June or like the 1 to 10 percent of patients who take the drug have done since it was approved last December.

No one should give up on Paxlovid, but we do need to temper our expectations of the drug and perhaps curtail our use of it in vaccinated people.

The Food and Drug Administration granted an Emergency Use Authorization (EUA) for Paxlovid after a study showed an 88 percent effectiveness in preventing severe disease, which the study defined as COVID-19-related hospitalization or death in patients at a higher risk of severe disease (over 60 years of age or presence of another risk factor such smoking history, being overweight, or chronic disease). Such a high rate of success made Paxlovid look like a dream come true.

But that study was conducted on unvaccinated subjects; it makes sense that it would be effective as compared to a control group of unvaccinated, untreated people. It made Paxlovid look more like a wonder drug than it deserved.

That may explain why providers are writing 40,000 Paxlovid prescriptions per day.

Not all of these prescriptions may be necessary. During the Omicron surge, two doses of a vaccine — even being more than six months out from the last shot — demonstrated 57 percent effectiveness in preventing hospitalization without any other treatments.

But with a recent booster shot, vaccination’s ability to prevent hospitalization increased to 90 percent. We don’t have data on booster shots’ effectiveness at preventing hospitalization with the currently dominant variants, BA.4 and 5, and we had some evidence that immunity wanes, even after patients’ third and fourth vaccines. Adding Paxlovid on top of that doesn’t provide that much more protection.

There are currently no peer-reviewed studies examining the real effectiveness of Paxlovid in vaccinated and/or boosted patients; early indications are that Paxlovid doesn’t lower the risk of hospitalization in 40-64-year olds. In 65 year and older patients, it lowers the risk of hospitalization by less than one percent.

Combining the Paxlovid interim data with the Omicron vaccine data, only one in 588 boosted patients without additional risk factors treated with Paxlovid will avoid severe disease.

It seems like a marginal benefit, especially when the pill poses the risk of this “rebound” among other side effects like a metallic taste or diarrhea. Many patients, like President Biden, have to temporarily stop some of their other medications. This seems like a minor inconvenience but skipping doses of medications like immunosuppressants and migraine treatments can cause a cascade of other health problems in certain patients.

The rebounds have non-medical consequences, too, even with the Centers for Disease Control and Prevention relaxing rules; people who test positive are still asked to quarantine. With these rebounds, patients miss more work and may lose income. As a physician, I experienced this myself. I rebounded and had to quarantine for 14 days, double the time I would have been isolated without the rebound.

The real problem with rebounds is that Paxlovid’s five-day course of treatment may not be enough to prevent them. Rebound patients are probably individuals who metabolize Paxlovid faster so that the drug never reaches an adequate level.

The EUA allows for a five-day course of treatment. A recent study found that more time spent taking Paxlovid may prevent the rebound so the drug would either require approval or the EUA would need to be modified. Studies that test a longer than five-day treatment course are currently underway.

The federal government paid for 20 million doses late last year. At our current rate of prescription, we will likely exhaust this supply next year. Paxlovid isn’t cheap; a five-day treatment course costs around $530. When our initial stockpile runs out, the issues of affordability and insurance coverage emerge and reignite the debate over access to health care.

Paxlovid is no ivermectin; its use isn’t entirely misplaced during the pandemic. For one, the use of Paxlovid in the unvaccinated is warranted, as it is in vaccinated people with a higher risk for severe disease. There’s also anecdotal evidence it helps with long COVID. Prescribing it to the president was completely reasonable.

But for the average vaccinated and recently boosted patient, it may not be. Physicians — and patients — need to keep that in mind.

Benjamin P. Geisler is a hospitalist.

Image credit: Shutterstock.com

Prev

What anticipatory grief feels like

September 10, 2022 Kevin 0
…
Next

Bulletproof backpacks: There's more we can do

September 10, 2022 Kevin 1
…

Tagged as: COVID, Infectious Disease

Post navigation

< Previous Post
What anticipatory grief feels like
Next Post >
Bulletproof backpacks: There's more we can do

More by Benjamin Geisler, MD, MPH

  • a desk with keyboard and ipad with the kevinmd logo

    Patients need help to navigate the health care system

    Benjamin Geisler, MD, MPH
  • a desk with keyboard and ipad with the kevinmd logo

    Can Medicaid be saved with better care coordination?

    Benjamin Geisler, MD, MPH
  • a desk with keyboard and ipad with the kevinmd logo

    A monetary value on each life saved

    Benjamin Geisler, MD, MPH

Related Posts

  • The COVID vaccine selfie: The caption matters as much as the picture

    Alicia Billington, MD, PhD
  • Where’s the big COVID data?

    Anuradha Kolluru, MD and Rakesh Lattupalli, MD
  • Major medical groups back mandatory COVID vaccine for health care workers

    Molly Walker
  • Before taking Paxlovid, consider these drug interactions

    Param Patel, PharmD
  • Is it time for a true federal COVID vaccine mandate?

    Shetal Shah, MD
  • COVID-19 divides and conquers

    Michele Luckenbaugh

More in Meds

  • 13.1 million missing Americans since 1980. Where’s the outrage?

    Steve Burgess, MD
  • Ketamine for mental health conditions: What every primary care physician needs to know

    Carlene MacMillan, MD & L. Alison McInnes, MD
  • Learn to be a Narcan hero: a comic tutorial

    Emily Watters, MD
  • The preference for insurance coverage of opioids over non-pharmaceutical options explained

    Amy Baxter, MD
  • A comic reveals the terrifying truth about fentanyl

    Emily Watters, MD
  • The importance of physician education regarding psilocybin therapy

    Lynn Marie Morski, MD, JD
  • Most Popular

  • Past Week

    • Ethical considerations in medicine: unity and open discourse

      Andrew Zywiec, MD | Physician
    • Unveiling excessive medical billing and greed

      Amol Saxena, DPM, MPH | Policy
    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
    • For newer doctors, avoid lifestyle inflation

      Amarish Dave, DO | Finance
    • Family support is pivotal in the treatment of schizophrenia

      Frank Chen, MD | Conditions
    • Chronic health issues and homelessness

      Michele Luckenbaugh | Policy
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Navigating the broken medical system: challenges faced by foreign medical graduates

      Anonymous | Physician
    • The essence of medicine: genuine connections in practice

      Jennifer Tillman, MD | Physician
    • 1 in 4 attempt suicide: the persecution of autistic physicians

      Patricia Celan, MD | Physician
  • Recent Posts

    • Family support is pivotal in the treatment of schizophrenia

      Frank Chen, MD | Conditions
    • Is emergency medicine your calling? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Exploring disfigurement and self-worth

      Kathleen Watt | Conditions
    • AI is living up to its promise as a tool for radiology

      Hoag Memorial Hospital Presbyterian | Tech
    • The shifting landscape of gastroenterology manpower and compensation

      Brian Hudes, MD | Physician
    • I’m tired of being a distracted doctor

      Shiv Rao, MD | Tech

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Loneliness Needs to Be Treated Like Any Other Health Condition, Researcher Suggests
  • 'Con Man' Gets Another Top Hospital Job, This Time at Penn Medicine
  • TikTok Dinged for Misinformation; BRCA Risk Overestimated; Cheers for Oncology
  • Flawed Rules in No Surprises Act Hurt Doctors and Patients, Experts Say
  • IG Live September 25: When the Healers Need Healing

Meeting Coverage

  • Loneliness Needs to Be Treated Like Any Other Health Condition, Researcher Suggests
  • Stopping Medical Misinformation Requires Early Detection
  • AI Has an Image Problem in Healthcare, Expert Says
  • Want Better Health Outcomes? Check Out What Other Countries Do
  • ERS Roundup: Cell Transplant Boosts Lung Function in COPD Patients
  • Most Popular

  • Past Week

    • Ethical considerations in medicine: unity and open discourse

      Andrew Zywiec, MD | Physician
    • Unveiling excessive medical billing and greed

      Amol Saxena, DPM, MPH | Policy
    • I’m a doctor, and I almost died during childbirth

      Bayo Curry-Winchell, MD | Physician
    • For newer doctors, avoid lifestyle inflation

      Amarish Dave, DO | Finance
    • Family support is pivotal in the treatment of schizophrenia

      Frank Chen, MD | Conditions
    • Chronic health issues and homelessness

      Michele Luckenbaugh | Policy
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Navigating the broken medical system: challenges faced by foreign medical graduates

      Anonymous | Physician
    • The essence of medicine: genuine connections in practice

      Jennifer Tillman, MD | Physician
    • 1 in 4 attempt suicide: the persecution of autistic physicians

      Patricia Celan, MD | Physician
  • Recent Posts

    • Family support is pivotal in the treatment of schizophrenia

      Frank Chen, MD | Conditions
    • Is emergency medicine your calling? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Exploring disfigurement and self-worth

      Kathleen Watt | Conditions
    • AI is living up to its promise as a tool for radiology

      Hoag Memorial Hospital Presbyterian | Tech
    • The shifting landscape of gastroenterology manpower and compensation

      Brian Hudes, MD | Physician
    • I’m tired of being a distracted doctor

      Shiv Rao, MD | Tech

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...